Treatment of lesions
AssigneeUniversity of Bath
InventorsDavid Russell Blake, Clifford Robert Stevens, Robert Eisenthal, Roger Harrison, Timothy Mark Millar, Tulin Bodamyali, Janos Kanczler
Life of this patent
Estimating the term…
Abstract
A composition for use in the treatment of lesions of the human or animal body comprises xanthine oxidoreductase and a pharmaceutically acceptable electron donor system. The composition can accelerate wound healing, especially in a hypoxic environment.
Claims16
A pharmaceutical composition comprising
- an amount of XOR effective for treatment or inhibition of lesions, of the human or animal body;
- a pharmaceutically acceptable electron donor system and
- at least one pharmaceutically acceptable excipient or carrier wherein said pharmaceutical composition is a cream, gel or ointment adapted for topical administration to the human or animal body.
A kit for use in the treatment of lesions, having at least two components, a first component of the system comprising a pharmaceutical composition comprising XOR and a second component of the system comprising a pharmaceutical composition comprising a pharmaceutically acceptable electron donor system, said first and second components being arranged for application to a surface of an animal or human body in combination or separately, simultaneously or sequentially, wherein each of the pharmaceutical compositions in the kit is a cream, gel or ointment.
A pharmaceutical composition for treating or inhibiting lesions of the human or animal body comprising:
- XOR;
- and
- at least one pharmaceutically acceptable carrier wherein the composition is a cream, gel, solution ointment adapted for topical administration and comprises from 0.1 μg to 1 mg XOR per gram of pharmaceutically acceptable carrier.
A pharmaceutical composition for topical administration to a human or animal patient, said pharmaceutical composition being a gel or cream comprising XOR.
Dependencies are inferred from the claim text.